Woodworth Emily 4

What Happened
Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific, had 838 restricted stock units (RSUs convert/ exercised) on 2026-03-01. The RSUs converted into 838 shares (exercise price $0.00). To cover tax obligations, 372 of those shares were withheld/disposed at $76.85 per share, totaling $28,588. Net shares delivered to Woodworth were 466 (838 vested − 372 withheld). This is a routine vesting/tax-withholding event, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-01; Form filed: 2026-03-03 (appears within the Form 4 reporting window).
• Exercise/conversion: 838 shares at $0.00 (reported as derivative exercise/ conversion).
• Tax withholding: 372 shares withheld/ disposed at $76.85/share = $28,588.
• Net shares issued to insider: 466 shares.
• Footnotes: F1 — each RSU represents the company’s commitment to issue one share; F2 — RSUs are paid in four equal annual installments beginning March 1, 2025 (this is a scheduled installment).
• Shares owned after the transaction are not specified in this filing.

Context
This was a scheduled RSU vesting with shares withheld to satisfy tax withholding — a common, administrative transaction that does not necessarily signal insider buying or selling intent. For derivative transactions like RSU conversion, the reported $0.00 exercise price means the shares were issued as compensation rather than purchased.